| Date | Title | Description |
| 10.09.2026 | European Tech Accelerates: AI Sales Automation Leads $17.5M Round, M&A Heats Up | Atira, a Munich AI powerhouse, secured $17.5 million in a combined Seed and Pre-seed round, led by Accel. This funding fuels its mission to automate complex industrial sales engineering, transforming a $128 billion global market. The invest... |
| 04.09.2026 | Atira erhält 15 Millionen – Pyure übernimmt klima&so – Callstack kauft Margelo | Im #DealMonitor für den 4. September werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor... |
| 15.07.2026 | Pearl Health Raises $50M to Help Providers Succeed in Value-Based Medicare Care | Medicare covers more than 70 million Americans and now consumes over $1 trillion in annual spending – yet the system still pays providers for the volume of services delivered, not for whether patients stay healthy. That misalignment has cre... |
| 11.07.2026 | Pearl Health Fuels Medicare AI Revolution with $110 Million | Pearl Health secures $110 million to expand its AI platform for Medicare. The NYC-based healthcare tech firm, backed by Andreessen Horowitz and Trinity Capital, targets enhanced risk management and superior patient outcomes. Funds will fuel... |
| 08.07.2026 | Pearl Health Raises $110 Million To Expand AI Platform For Medicare Care | (See Pulse 2.0 profile here)
Pearl Health announced a $110 million capital raise to expand its AI platform for providers caring for Medicare patients. The financing includes a $50 million equity round led by Andreessen Horowitz and a $60 mi... |
| 08.07.2026 | Pearl Health Raises $110M in Funding | Pearl Health, a NYC-based healthcare technology company helping manage risk and deliver better care to Medicare patients, raised $110M in funding.
The round consisted of a $50M in equity funding led by Andreessen Horowitz with participation... |
| 16.06.2026 | GT Medical Technologies Secures $100M to Revolutionize Brain Tumor Treatment | GT Medical Technologies secured $100 million in oversubscribed Series E funding. Viking Global Investors led the round. These funds will fuel aggressive commercial expansion and advance critical clinical trials. The company's innovative Gam... |
| 11.06.2026 | GT Medical Technologies Raises $100 Million Series E Financing To Advance Brain Tumor Treatment Platform | GT Medical Technologies announced the completion of an oversubscribed $100 million Series E financing round led by new investor Viking Global Investors, with participation from existing investors including MVM Partners, Gilde Healthcare, Ev... |
| 09.06.2026 | City Therapeutics Raises $99.5M in Series B Funding | City Therapeutics, Inc., a Cambridge, MA-based biopharmaceutical company developing RNA interference (RNAi)-based medicines, raised $99.5M in Series B funding.
The round was led by Viking Global Investors and Sofinnova Investments with part... |
| 09.06.2026 | GT Medical Technologies Raises $100M in Series E Funding | GT Medical Technologies, Inc., a Tampa, AZ-based medical device company dedicated to improving the lives of patients with brain tumors, raised $100M in Series E funding.
The round was led by Viking Global Investors with participation from e... |
| 19.01.2026 | Here’s how much money the world’s biggest hedge funds made in a record-breaking 2025 | - |
| 11.01.2026 | Diagonal Therapeutics Secures $125M to Propel Innovative Antibody Therapies | Diagonal Therapeutics secured $125M Series B funding. This advances DIAG723, a first-in-class clustering antibody. It targets hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH). The Watertown biotech corre... |
| 11.01.2026 | Diagonal Therapeutics: $125 Million Series B Raised To Advance DIAG723 Clustering Antibody Into the Clinic | Diagonal Therapeutics announced it has raised $125 million in an oversubscribed Series B financing to advance its lead program, DIAG723, a first-in-class “clustering antibody” designed to correct dysregulated receptor signaling implicated i... |
| 09.01.2026 | Diagonal Therapeutics Raises $125M in Series B Financing | Diagonal Therapeutics, a Watertown, MA-based biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, raised $125M in Series B Funding.
The round was co-led by ... |
| 19.12.2025 | Medline's Monumental IPO: A Beacon Amidst Market Turbulence | Medline's colossal $6.26 billion initial public offering seized market attention. The medical supply giant's debut stands as the largest U.S. offering since 2021. Its shares experienced a significant post-listing surge. This strong performa... |
| 17.12.2025 | Американский производитель медтоваров Medline привлек $6,26 млрд в крупнейшем IPO года | Акции Medline Inc. выросли на 21% в день начала торгов после того, как поставщик медицинской продукции привлек $6,26 млрд в крупнейшем первичном публичном размещении акций в этом году.
Торги начались по цене $35 за акцию против цены размеще... |
| 16.12.2025 | Allonnia Secures $20M+ to Revolutionize Mineral Extraction | Allonnia, a Boston-based biotech firm, just closed a $20 million+ Series A extension. This brings total funding past $100 million. The company aims to improve mineral recovery and lessen environmental damage. Demand for critical minerals is... |
| 12.12.2025 | Allonnia: Over $20 Million In Series A Extension Closed To Advance Critical Materials Biotechnology | Allonnia, a Boston-based bio-ingenuity company focused on improving mineral recovery while reducing environmental impact, has raised more than $20 million in a Series A extension round. The financing was led by Viking Global Investors, Biso... |
| 10.12.2025 | Allonnia Raises More Than $20M in Series A Extension Funding | Allonnia, a Boston, MA-based bio-ingenuity company that develops scalable solutions to improve mineral recovery and reduce environmental impact, raised more than $20M in Series A extension funding.
The round was led by Viking Global Investo... |
| 20.10.2025 | Veradermics: $150 Million Series C Raised For Advancing Late-Stage Trials Of VDPHL01 | Veradermics, a dermatologist-founded, late clinical-stage biopharmaceutical company developing first-in-class treatments for common dermatologic conditions, has announced the completion of an oversubscribed $150 million Series C financing r... |
| 16.10.2025 | Rockefeller Capital: $6.6 Billion Valuation Secured In Recapitalization With New Investor Group | Rockefeller Capital Management announced a major recapitalization that values the firm at more than $6.6 billion, marking a pivotal step in its long-term growth strategy. The deal brings new distinguished families and investors into the fir... |
| 14.10.2025 | Rockefeller Capital secures backing from Chanel dynasty’s family office and others | Sign up for the new Inside Alts newsletter
Rockefeller Capital Management, the wealth manager born from the Rockefeller heirs’ family office, is valued at $6.6 billion after new investment, CNBC has learned.
The recapitalization was led by ... |
| 12.10.2025 | Star Therapeutics: $125 Million Series D Raised For Developing Antibodies For Bleeding Disorders | Star Therapeutics, an innovative clinical-stage biotechnology company, is dedicated to discovering and developing cutting-edge antibodies aimed at treating bleeding disorders and other medical conditions. The company recently announced the ... |
| 01.10.2025 | Verdane: Freya XII Fund Closed At €2 Billion | Verdane, an investment firm specializing in the European lower mid-market, announced the final closing of its latest fund, Verdane Freya XII, at its maximum hard cap of €2 billion. This achievement not only sets a record as the largest fund... |
| 01.10.2025 | Star Therapeutics Raises $125M in Series D Financing | Star Therapeutics, a San Francisca, CA-based clinical stage biotechnology company discovering and developing antibodies for bleeding disorders and other diseases, raised $125M Series D funding.
The round was co-led by Sanofi Ventures and Vi... |
| 26.09.2025 | Ensoma Secures $53M to Accelerate In Vivo Stem Cell Gene Therapies | Ensoma has secured $53 million in a pivotal funding round. This capital infusion accelerates its groundbreaking work in one-time, in vivo stem cell therapies. A primary goal involves progressing the Phase 1/2 clinical trial for EN-374, spec... |
| 23.09.2025 | Ensoma Raises $53M in Funding | Ensoma, a Boston, MA-based in vivo hematopoietic stem cell (HSC) engineering company, raised $53M in funding.
Backers included Gilead (Nasdaq: GILD), which has also appointed an executive to the Ensoma board of directors as part of its inve... |
| 23.09.2025 | Ensoma: $53 Million Secured To Advance Stem Cell Therapies And Global Clinical Impact | Ensoma, a biotechnology company focused on transforming medicine through one-time, in vivo stem cell therapies, has announced the closing of a $53 million funding round. This investment comes from a group of leading investors who have previ... |
| 30.07.2025 | European Tech Accelerates: Billions Flow, AI Leads Innovation | European technology firms are attracting significant investment. Lightyear, an investment platform, secured a $23 million Series B round, pushing customer assets past $1 billion. The company launched advanced AI market intelligence tools, p... |
| 25.07.2025 | CEE Tech Weekly: Poland, Estonia, and Bulgaria with Major Deals | Central and Eastern Europe ~
Company:
The Recursive’s new weekly roundup aims to cover key tech developments across Central and Eastern Europe, as well as the growing impact of CEE-born founders on the global stage. Take a look at the lates... |
| 22.07.2025 | BiomEdit Forges New Path in Animal Health with Major Advances and Strategic Funding | BiomEdit, a leading animal health biotechnology firm, announced major advancements. Its pioneering poultry solution, BE-101 (Optavant™), a non-antibiotic treatment for necrotic enteritis in broiler chickens, entered the final USDA condition... |
| 16.07.2025 | BiomEdit Advances First-of-Its-Kind Engineered Bacteria Product to Final Development Phase, Secures Series B Funding, Adds Key Industry Leadership | BiomEdit logo
Poultry industry's first engineered probiotic biologic moves into final development and regulatory stages for USDA conditional licensure and commercial scale-up
GREENFIELD, Ind., July 16, 2025 /PRNewswire-PRWeb/ -- BiomEdit, a... |
| 20.06.2025 | Verb Biotics on next gen biotics: ‘We’re function-first, and we’re not tied into any one organism or flagship strain’ | Many companies in the probiotics space start with a flagship strain and then study it to determine potential health benefits. Microbiome health startup Verb Biotics flips that on its head, claims CEO Todd Beckman.
“We’re function-first, and... |
| 08.06.2025 | Antheia's $56 Million Boost: A Game Changer in Pharmaceutical Manufacturing | Antheia, a Menlo Park-based pharmaceutical ingredient manufacturer, has struck gold with its recent $56 million Series C funding round. This infusion of capital, led by the Global Health Investment Corporation (GHIC), marks a significant le... |
| 07.06.2025 | Antheia: $56 Million Series C Raised For Advancing Global Commercialization Strategy | Antheia, a pharmaceutical ingredient manufacturer transforming essential medicine supply chains, announced it has raised $56 million in Series C financing. The Series C funding round was led by Global Health Investment Corporation (GHIC), a... |
| 15.05.2025 | Ole Andreas Halvorsen’s Viking Global bet on banks and more than doubled its stake in Nvidia in the first quarter | - |
| 02.05.2025 | Canopy's $70 Million Leap: Transforming Accounting with AI | In the bustling world of finance, change is the only constant. Canopy, a pioneer in accounting practice management, has just secured a hefty $70 million in Series C funding. This investment, led by Viking Global Investors, is a bold step to... |
| 01.05.2025 | Canopy: $70 Million Series C Raised For AI-Based Accounting Platform | Canopy, a company that has built a firm-wide operating system designed to help accountants operate the accounting firm of the future, announced a $70 million Series C funding round. Viking Global Investors (a global investment firm with ove... |
| 30.04.2025 | Canopy Raises $70M in Series C Funding | Canopy, a Salt Lake City, UT-based provider of a firm-wide operating system for accounting, raised $70M in Series C funding.
The round was led by Viking Global Investors with participation from existing investors Ten Coves Capital, Ankona C... |
| 29.04.2025 | Canopy Secures $70 Million Series C to Unclunk Accounting Firms with AI | Viking Global Investors Leads Round to Double Down on AI Product Investment
SALT LAKE CITY–(BUSINESS WIRE)–April 30, 2025–
Canopy, the firm-wide operating system designed to help accountants operate the accounting firm of the future, has an... |
| 23.04.2025 | Canopy Secures $70 Million Series C to Unclunk Accounting Firms with AI | Canopy Accounting Practice Management Software
Viking Global Investors Leads Round to Double Down on AI Product Investment
Our mission is to help accountants apply their expertise to delivering real value to clients–with AI we’re now automa... |
| 18.03.2025 | Patina Launches New Service, Patina Total Health (TM), to Make Personalized, Age-Friendly Care Accessible to Medicare Advantage Members | Patina Logo
Patina's population health service to improve member experience, reduce total cost of care, improve quality and STAR ratings, and drive value-based outcomes at scale.
PHILADELPHIA, March 18, 2025 /PRNewswire-PRWeb/ -- Patina, th... |
| 20.02.2025 | US hedge fund shorts British firms despite aim to ‘save’ UK market | - |
| 22.11.2024 | Metsera: $215 Million (Series B) Raised To Develop Medicines For Obesity And Metabolic Diseases | Metsera – a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases – announced the closing of a $215 million Series B funding round to further advance its portfolio of highl... |
| 14.11.2024 | Metsera Raises $215M in Series B Financing | Metsera, a NYC-based clinical-stage biopharmaceutical company, raised $215M in Series B funding.
The round was led by Wellington Management and Venrock, with participation from Fidelity Management and Research Company, Janus Henderson Inves... |
| 04.10.2024 | Triveni Bio: $115 Million (Series B) Closed To Advance Novel Antibody Treatments For I&I Disorders | Triveni Bio, a biotech company advancing novel antibody treatments for I&I disorders, announced a $115 million Series B to support pipeline expansion. The funding round was led by Goldman Sachs Alternatives with significant participatio... |
| 28.07.2024 | The Surge of Innovation: How Magenta Medical and Brenig Therapeutics are Shaping the Future of Healthcare | In the world of healthcare, innovation is the lifeblood that keeps the industry thriving. Two companies, Magenta Medical and Brenig Therapeutics, are at the forefront of this revolution. With significant funding rounds recently completed, t... |
| 26.07.2024 | Magenta Medical: Heart Pump Company Raises $105 Million | Magenta Medical, the developer of Elevate (the world’s smallest heart pump), announced it had closed a $105 million funding round led by global healthcare investment firm Novo Holdings. The new investors Viking Global Investors and RA Capit... |
| 25.07.2024 | Antheia: Pharmaceutical Ingredient Producer Secures $17 Million In New Funding | Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, announced $17 million in new funding through a government project agreement through the Biopharmaceutical Manufacturing Preparedness Consorti... |
| 21.06.2024 | AlphaSense Makes Strategic Move with Tegus Acquisition and $650M Funding Boost | In a bold strategic move, AlphaSense, a prominent player in the market intelligence realm, has announced the acquisition of Tegus in a deal valued at $930 million. This acquisition comes hand in hand with a substantial funding injection of ... |
| 21.06.2024 | Market Intelligence Company AlphaSense Buying Tegus And Raises $650 Million At $4 Billion Valuation | AlphaSense, a leading market intelligence and search platform, announced an agreement to buy Tegus, a leading provider of expert research, unique private company content, and financial data and workflow tools. As part of this deal, AlphaSen... |
| 11.06.2024 | AlphaSense buys private market rival Tegus for $930M | figcaption>span]:font-sans" data-chromatic="ignore">
Market intelligence unicorn AlphaSense on Tuesday agreed to acquire competitor Tegus for $930 million in cash and stock, and it inked a new fundraising round that val... |
| 22.05.2024 | Pearl Health releases Top 50 Value-Based Care Thinkers of 2024 | NEW YORK, May 22, 2024 /PRNewswire/ -- Pearl Health today released its third annual Top 50 Value-Based Care Thinkers report, which recognizes healthcare providers, policy makers, academics, and thinkers across disciplines who are leading th... |
| 02.04.2024 | 🎥 Futureproofing the botanicals supply chain with plant cell culture startup Ayana Bio | Spun off from Ginkgo Bioworks in 2021, Ayana Bio is one of a new wave of startups in plant cell culture, growing botanicals in bioreactors instead of fields. We caught up with CEO Frank Jaksch at the Future Food Tech conference in San Franc... |
| 09.02.2024 | Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics | 09/02/2024
Nota de prensa
YSIOS CAPITAL INVIERTE EN LA SERIE E DE 120 MILLONES DE DÓLARES DE NEURONA THERAPEUTICS
Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la rond... |
| 03.01.2024 | Ecovative CEO: ‘We’re introducing a new industrial crop to the world’ | Founded in 2007 by mechanical engineering students Eben Bayer and Gavin Mclntyre, Ecovative is one of several startups attempting to harness the magic of mycelium—the filament-like roots of mushrooms—to make more sustainable foods and mater... |
| 12.06.2023 | 🎥 Verb Biotics: Next gen ‘precision biotics’ will deliver ‘measurable effects that consumers can feel’ | Microbiome health startup Verb Biotics is gearing up to launch its first products in the first quarter of 2024, two and a half years after it was spun out of synthetic biology company Ginkgo Bioworks.
Launched in September 2021 with $30 mil... |
| 06.06.2023 | Meat from mycelium: MyForest Foods raises $15m Series A-2, hires new CEO, teases new product | MyForest Foods Co, a New York-based startup making meat alternatives from mushroom mycelium, has raised $15 million in Series A-2 funding and hired Greg Shewchuk as CEO as it ramps up distribution of its first product: MyBacon.
Spun out in ... |
| 19.04.2023 | BREAKING: Ayana Bio unveils first ingredients made using plant cell culture as cracks show in strained botanical supply chain | Ayana Bio has launched its first ingredients (lemon balm and echinacea) made via plant cell culture, an approach it claims can provide a consistent supply of botanicals without the supply chain headaches associated with traditional agricult... |
| 26.01.2023 | Pearl Health Raises $75M to Expand Value-Based Care Innovation | What You Should Know:
Pearl Health’s technology uses data science to help primary care providers focus their attention on the patients who are most likely to need it, enabling physicians and clinical staff to move toward a more proactive ca... |
| 26.01.2023 | Pearl Health Rakes In $75M to Enable More Physician Participation in VBC | Investors are continuing to funnel big bucks into alternative payment models. The latest example of this comes from Pearl Health, a New York City-based technology company that helps independent physician practices participate in value-based... |
| 19.01.2023 | SetPoint Medical Raises $80M to Advance Platform for Autoimmune Diseases | What You Should Know: |
| 16.06.2022 | AlphaSense raises $225 million funding led by Goldman Sachs, Viking Global at $1.7 billion valuation | New York-based market intelligence platform AlphaSense has raised $225 million in Series D funding round, led by the Growth Equity business within Goldman Sachs Asset Management and Viking Global Investors. The new round also includes an un... |
| 21.04.2022 | Revenova Raises $63 Million from Viking Global Investors to Accelerate Innovation in Transportation Technology | Salesforce Partner Since 2014
BANNOCKBURN, IL, US, April 21, 2022 /EINPresswire.com/ -- Revenova, the leading transportation management system (TMS) provider, today announced it has raised $63 million from Viking Global Investors. This inve... |
| 13.04.2022 | Brief: Ginkgo Bioworks and Elanco launch animal health company BiomEdit | US synthetic biology company Ginkgo Bioworks and Elanco Animal Health Incorporated are launching a “microbiome innovation” company that will develop microbiome-based products and services for improved animal health. The new company, called ... |
| 17.02.2022 | U.S. Global Investors Announces Second-Quarter Net Income of $3.6 Million, an Increase of 50% from Previous Quarter | San Antonio, TX, Feb. 17, 2022 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors from gold mining to ... |
| 10.02.2022 | And the money kept rollin’ in from every side: Cazoo brings home $630 million | It wouldn’t be a fortnight without online car retailer Cazoo either making an acquisition or raising a boatload of money. This time, it’s the latter as the publicly listed company reports a new influx of capital to the tune of $630 million.... |
| 25.01.2022 | Fluidigm : Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc - Form 8-K | Fluidigm Announces $250 Million Strategic Capital Infusion from
Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.
Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Plat... |
| 24.01.2022 | Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc. | Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions
Dr. Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Boa... |
| 24.01.2022 | Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc. | Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions
Dr.
Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Boa... |
| 13.01.2022 | Global Processing Services adds $100M to its coffers to grow its embedded finance and API payments platform | Embedded finance continues to be the engine driving the growth of fintech, with one group of companies building core banking, payments and other financial technology, and a much bigger group tapping that technology through APIs to build cus... |
| 09.12.2021 | U.S. Global Investors Announces Record Net Income of $32 Million in Fiscal Year 2021, Continuation of Dividends | San Antonio, TX, Dec. 08, 2021 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a boutique registered investment advisory firm with longstanding experience in global markets and specialized sectors from gold t... |
| 08.12.2021 | U.S. Global Investors Announces Record Net Income of $32 Million in Fiscal Year 2021, Continuation of Dividends | San Antonio, TX, Dec. 08, 2021 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a boutique registered investment advisory firm with longstanding experience in global markets and specialized sectors from gold t... |
| 30.11.2021 | Exclusive-Vingroup tapping global investors for car unit's $1 billion funding - sources | The fundraising exercise comes as VinFast, Vingroup's automobile arm, is betting big on the U.S. market, where it hopes that its electric SUVs and a battery leasing model will be enough to woo consumers away from the likes of Tesla and Gene... |
| 30.11.2021 | Exclusive-Vingroup tapping global investors for car unit's $1 billion funding - sources | By Anshuman Daga
SINGAPORE (Reuters) -Vietnam's largest conglomerate Vingroup is in talks with investors, including Qatar's sovereign fund and BlackRock, to raise about $1 billion in equity for its car unit, three sources aware of the matte... |
| 26.10.2021 | Patina Emerges Out of Stealth with $50M to Reinvent Primary Care & Aging Experience | What You Should Know:
– Patina Health Inc. (PatinaTM) came out of stealth today to announced its $57M Series A round from healthcare investors Andreessen Horowitz (a16z) and GV (formerly Google Ventures), who co-led the Seed and Series A ro... |
| 13.09.2021 | Global investors led $120 M funding raised by Egyptian fintech startup MNT-Halan | MNT-Halan began as a two- and three-wheeler ride-hailing service in 2018, and has since grown to become Egypt’s largest and fastest-growing unbanked lender.
Through its consumer-facing app, merchant app, distributed lending, and payment pro... |
| 25.08.2021 | Soil biology specialist Biome Makers bags $15m Series B funding | US-based soil testing startup Biome Makers has raised $15 million in a Series B round led by Prosus Ventures – a VC affiliate of South African internet giant Naspers. Other investors joining the round included Spanish firms JME Ventures and... |
| 25.08.2021 | Biome Makers Inc announces $15M Series B round led by Prosus Ventures, and also backed by Seaya, Viking Global, JME Ventures and Pymwymic | 25/08/2021
Press release
BIOME MAKERS INC ANNOUNCES $15M SERIES B ROUND LED BY PROSUS VENTURES, AND ALSO BACKED BY SEAYA VENTURES, VIKING GLOBAL INVESTORS, JME VENTURES AND PYMWYMIC.
West Sacramento, CA – Biome Makers Inc., the internati... |
| 18.08.2021 | Apeel raises $250m Series E to expand supply networks, fund tech acquisitions | Disclosure: AFN’s parent company, AgFunder, is an investor in Apeel via the latter’s acquisition of ImpactVision.
Food waste reduction company Apeel has just closed a $250 million Series E round, bringing its total funding to $635 million a... |
| 30.07.2021 | Gopuff valued at US$15 billion after raising funds from global investors | REUTERS -Delivery startup Gopuff said on Friday it raised US$1 billion from global investors, including Guggenheim Investments and SoftBank Vision Fund 1, valuing the company at around US$15 billion.
The new valuation represents a jump of n... |
| 16.06.2021 | Motif FoodWorks raises $226m to tackle plant-based’s challenges with texture & taste | Alt-protein company Motif FoodWorks has raised $226 million in Series B funding. The round was jointly led by Ontario Teachers’ Pension Plan Board — through its Teachers’ Innovation Platform — and funds and accounts managed by BlackRock.
Ai... |
| 15.04.2021 | Atlast raises $40m to make mycelium-based whole cuts | US alt-protein startup Atlast has raised $40 million in a Series A round led by Viking Global Investors. Also participating in the round were 40 North – an investment fund affiliated with building materials manufacturer Standard Industries ... |
| 11.03.2021 | CBRE Global Investors raises $100m so far for Japan-focused fund | Premium
Real asset investment management firm CBRE Global Investors has raised $100 million so far for a Japan-focused logistics fund, CBRE Asia Value V Japan Logistics Co-Investment SCSp, its filing with the US Securities and Exchange Comm... |
| 29.01.2021 | EXCLUSIVE: Resilient Biotics raises $7.1m from Elanco, others to create livestock microbiome medicines | North Carolina-based biotech startup Resilient Biotics has raised $7.1 million in a Series A round co-led by Berkeley Catalyst Fund and Fulcrum Global Capital.
Other investors joining the round included Elanco Animal Health, Innovation in M... |
| 19.11.2020 | Pharvaris Announces $80 Million Series C Financing | |
| 19.11.2020 | Pharvaris Announces $80 Million Series C Financing | Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic condition with symptoms that include episodes of debilitating and often painful swelling in the hands, feet, face (lips and tongue), gastrointestinal tract, urog... |
| 21.09.2020 | MPL joins fundraising bandwagon, scoops up $90 mn from global investors | Binu Paul 21 Sep, 2020
As the gaming industry continues to witness increasing customer engagement amid the Covid-19 pandemic, mobile esports platform Mobile Premier League (MPL) is the latest startup in the segment to join the fundraising b... |
| 25.06.2020 | EXCLUSIVE: Boost Biomes nabs $5m Series A to tap into ecology of microbes | The biologics space is growing at a rapid space. Players are taking a variety of approaches to unlock the potential behind the microscopic organisms that dwell below the soil’s surface. From using microbes as unique fingerprints for traceab... |
| 10.03.2020 | CBRE Global Investors closes fifth Asia real estate fund at $900m | Premium
Real asset investment management firm CBRE Global Investors has marked the final close of its latest fund – CBRE Asia Value Partners V – at its hard cap of $900 million, lower than the $1 billion that its predecessor fund raised in ... |
| 10.03.2020 | CBRE Global Investors raises $900m | The global real asset manager has reached final close on its value-add fund. |
| 10.12.2019 | Iterable, founded by an ex-Twitter engineer, nabs $60M for cross-channel growth marketing tools | A startup that’s built cross-channel growth marketing platform — used by businesses to capture customers across whatever digital media they happen to be using — is today announcing funding to do some growing of its own. Iterable — which use... |
| 07.08.2019 | Biome Makers secures $4m Series A in another sign that investors are digging soil science startups | Are you a terroir-ist? If so, you’ll understand — along with almost any winegrower — how sexy soil can be. Beneath any field’s surface, a complex interplay of millions of micro-organisms thrives, defining whether a crop flourishes or wither... |
| 16.05.2019 | Impossible Foods eyes Asia, Europe after $300m celebrity whopper | Plant-based protein maker Impossible Foods — which designs vegan burgers that simulate the oozing, bleeding effect you get with rare meat — has closed another private funding round this week, securing a further $300 million of capital and b... |
| 20.03.2018 | The $100m Bayer, Ginkgo Bioworks Joint Venture Has a Name, a CEO, and a Plan | The joint venture (JV) between Bayer Crop Science and Boston startup Ginkgo Bioworks has a name: Joyn Bio.
Bayer and Ginkgo, a startup genetically engineering microbes for the flavor, fragrance, and food industries with $429 million in fund... |
| 27.02.2018 | Boost Biomes Launches Microbe Discovery Platform with $2m Seed Round | San Francisco-based Boost Biomes has raised a $2.05 million seed round to continue to develop its DNA-sequencing- based microorganism discovery platform, led by Nimble Ventures and hedge fund Viking Global Investors. Chinese internet, mobil... |
| 21.12.2017 | The Top 10 Farm Tech Deals of 2017 (How Many Can You Name Without Clicking?) | It was an exciting year in farm technology involving a few high profile venture capital exits and some of the largest deals on record.
In fact, funding records for this category and the subcategories within were broken more than once during... |
| 14.09.2017 | Bayer Joins Forces with Ginkgo to Launch $100m Microbial Startup | German agribusiness Bayer CropScience and Ginkgo Bioworks, a startup genetically engineering microbes for the flavor, fragrance, and food industries, have partnered with hedge fund Viking Global Investors to invest $100 million in a new, as... |
| 07.06.2017 | Internos Global Investors raises €133m | View the latest capital raises |
| 27.02.2017 | 16 early-stage healthtech startups you need to know | From online marketplaces to wearables for mothers, these are the fastest-growing healthtech startups
Editor's note: Our Splash Health, Wellness and Wearables event is coming up on March 23 in San Francisco. We'll have Mario Schlosser (Found... |
